The Hydration Pharmaceuticals Company Limited reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was USD 10.04 million compared to USD... The Hydration Pharmaceuticals Company Limited reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was USD 10.04 million compared to USD 9.1 million a year ago. Net loss was USD 8.1 million compared to USD 10.61 million a year ago. Basic loss per share from continuing operations was USD 0.04 compared to USD 0.07 a year ago. Diluted loss per share from continuing operations was USD 0.04 compared to USD 0.07 a year ago.
